INDGN2025-04-012025-06-30INDGN2025-06-30INDGN2025-04-012025-06-30in-capmkt:OtherExpenses1MemberINDGN2025-04-012025-06-30in-capmkt:ReportableSegments1MemberINDGN2025-04-012025-06-30in-capmkt:ReportableSegments2MemberINDGN2025-04-012025-06-30in-capmkt:ReportableSegments3MemberINDGN2025-04-012025-06-30in-capmkt:ReportableSegments4MemberINDGN2025-04-012025-06-30in-capmkt:ReportableSegments1MemberINDGN2025-04-012025-06-30in-capmkt:ReportableSegments2MemberINDGN2025-04-012025-06-30in-capmkt:ReportableSegments3MemberINDGN2025-04-012025-06-30in-capmkt:ReportableSegments4MemberINDGN2025-04-012025-06-30in-capmkt:ReportableSegments1MemberINDGN2025-06-30in-capmkt:ReportableSegments1MemberINDGN2025-04-012025-06-30in-capmkt:ReportableSegments2MemberINDGN2025-06-30in-capmkt:ReportableSegments2MemberINDGN2025-04-012025-06-30in-capmkt:ReportableSegments3MemberINDGN2025-06-30in-capmkt:ReportableSegments3MemberINDGN2025-04-012025-06-30in-capmkt:ReportableSegments4MemberINDGN2025-06-30in-capmkt:ReportableSegments4MemberINDGN2025-04-012025-06-30in-capmkt:ReportableSegments1MemberINDGN2025-06-30in-capmkt:ReportableSegments1MemberINDGN2025-04-012025-06-30in-capmkt:ReportableSegments2MemberINDGN2025-06-30in-capmkt:ReportableSegments2MemberINDGN2025-04-012025-06-30in-capmkt:ReportableSegments3MemberINDGN2025-06-30in-capmkt:ReportableSegments3MemberINDGN2025-04-012025-06-30in-capmkt:ReportableSegments4MemberINDGN2025-06-30in-capmkt:ReportableSegments4MemberINDGN2025-04-012025-06-30ItemsThatWillNotBeReclassifiedToProfitAndLoss1INDGN2025-04-012025-06-30ItemsThatWillBeReclassifiedToProfitAndLoss1INDGN2025-04-012025-06-30AuditorDomain1iso4217:INRiso4217:INRxbrli:shares544172INDGNNOTLISTEDINE065X01017Indegene LimitedMain BoardEquity2025-04-012026-03-312025-07-312025-07-24INRMillionsQuarterlyFirst quarterMulti segment2025-07-3116:40:002025-07-3116:58:00Declaration of unmodified opinion2025-04-012025-06-30UnauditedConsolidated7608000000221000000782900000000048150000003700000021600000012400000006308000000152100000001521000000284000000730000003570000000116400000000001164000000167000000133100000011640000000167000000133100000047900000024.864.82004.864.82Earnings per share is not annualised for quarter ended <BR> <BR> Notes to the Statement of Consolidated Financial Results for the quarter ended 30 June 2025 <BR> All amounts in INR millions except share data and where otherwise stated <BR> 1 The above Consolidated Financial Results of Indegene Limited the Company or the Parent or the Holding Company together with its affiliates collectively the Group have been prepared in accordance with Indian Accounting Standards Ind AS 34 Interim Financial Reporting recognition and measurement principles of Indian Accounting Standards Ind AS prescribed under Section 133 of the Companies Act 2013 as amended read with the relevant rules issued thereunder and in terms of Regulation 33 of the SEBI Listing Obligations and Disclosure Requirements Regulations 2015 the Regulations Due to rounding off the numbers presented throughout may not add up precisely to the totals The symbol caret in the financial information denote amounts less than INR 5 lakhs <BR> 2 The above consolidated results have been reviewed by the Audit Committee meeting held on 29 July 2025 and approved by the Board of Directors at its meeting held on 31 July 2025 The statutory auditors have performed a limited review of the Consolidated Financial Results for the quarter ended 30 June 2025 and have issued an unmodified review report on the same <BR> 3 The Consolidated Financial Results include the results for the quarter ended 31 March 2025 being the balancing figures between audited figures in respect of the full financial year up to 31 March 2025 and the unaudited published year to date figures up to 31 December 2024 being the date of the end of the third quarter of the financial year which were subjected to a limited review <BR> 4 The Consolidated Financial Results for the quarter ended 30 June 2025 are available on the National Stock Exchange of India Limited URL www nseindia com the BSE Limited website URL www bseindia com and on the Company s website URL www indegene com investorrelations <BR> 5 Acquisition of MJL Communications Group Ltd <BR> On 25 March 2025 the Group had obtained control of MJL Communications Group Ltd MJL by acquiring 100 percent of its shares The acquisition was consummated for a consideration of INR 411 which includes earnout payment of INR 150 The contingent consideration is based on the performance of MJL during the fiscal year beginning 01 April 2025 and ending 31 March 2027 and range of contingent consideration payable is between Nil to INR 172 The Group has concluded that the acquisition is a Business <BR> The fair value of net assets acquired on the acquisition date as a part of the transaction amounted to INR 98 The excess of purchase consideration over the fair value of net assets acquired has been attributed towards the identifiable intangible assets aggregating to INR 174 and goodwill aggregating to INR 139Other expenses1240000000Enterprise Medical Solutions2132000000Enterprise Commercial Solutions4453000000Brand Activation758000000Others265000000760800000007608000000Enterprise Medical Solutions576000000Enterprise Commercial Solutions1048000000Brand Activation51000000Others-50000000162500000037000000670000001521000000Enterprise Medical Solutions0Enterprise Commercial Solutions0Brand Activation0Others0000Enterprise Medical Solutions0Enterprise Commercial Solutions0Brand Activation0Others00006 The Segment results of the Group has been prepared in accordance with Ind AS 108 on Operating Segments The Group has identified business segments industry practice as reportable segments The reportable business segments comprise 1 Enterprise Medical Solutions 2 Enterprise Commercial Solutions 3 Brand Activation <BR> <BR> Effective 1 April 2025 the Omnichannel Activation segment has been renames as Brand Activation <BR> Others mainly comprises of consultancy and clinical business <BR> <BR> Notes on Segment information <BR> Operating segments are identified as components of an enterprise for which discrete financials information is available that is evaluated regularly by the chief operating decision maker In deciding how to allocate resources and assessing performance the Group s chief operating decision maker is the Chief Executive Officer and Executive Director <BR> Assets and liabilities used in the Group s business are not identified to any of the operating segments as these are used interchangeably between segments Management believes that it is currently not practicable to provide segment disclosures relating to total assets and liabilities since a meaningful segregation of the available data is onerous <BR> <BR> 7 Final dividend for the Financial Year 2024 25 of INR 2 per share was approved by the shareholders at the 27th Annual General Meeting held on 26 June 2025 and the same was paid on 30 June 2025 <BR> <BR> Other unallocable expenditure net of unallocable income for the three months ended 30 Jun 2025 includes depreciation and amortisation expense INR 216 and unallocable expenses INR 72 net of other income INR 221 Remeasurement of defined benefit obligation12000000120000003000000Exchange differences on translating the financial statements of foreign operations1580000001580000000167000000UnauditedtrueDeloitte Haskins & Sellstrue2028-04-30